Great News
• AusCann’s first harvest in Chile on track for April 2017commercial sales
• Eight different strains are being grown providing a range of chemical entities/
chemotypes to be used in trial formulations
• Product intended to be sold to third parties for use in a range of clinical trials later
this year
• Successful trials will result in product registration driving demand and subsequent
GLTAH
TW